HIF Stabilizers Get in Sync: Are ESAs Bye Bye Bye? in: Kidney News Volume 13 Issue 3 (2021)
Ap romising novelt herapeutic approach for the treatment of anemia:... | Download Scientific Diagram
Hypoxia-Inducible Factor Stabilizers for Treating Anemia of CKD in: Kidney News Volume 12 Issue 2 (2020)
HIF PHI Trials in CKD non-dialysis and dialysis: What do the data really show?
Hif ph inhibitors for anemia in ckd | PPT
Anemia of Chronic Kidney Disease: Will New Agents Deliver on Their Promise?
Cureus | An Overview of Safety and Efficacy Between Hypoxia-Inducible Factor-Prolyl-Hydroxylase Inhibitors and Erythropoietin-Stimulating Agents in Treating Anemia in Chronic Kidney Disease Patients | Article
HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond | Nature Reviews Nephrology
Molecules | Free Full-Text | Recent Advances in Developing Inhibitors for Hypoxia-Inducible Factor Prolyl Hydroxylases and Their Therapeutic Implications
Cardiac and Kidney Adverse Effects of HIF Prolyl-Hydroxylase Inhibitors for Anemia in Patients With CKD Not Receiving Dialysis: A Systematic Review and Meta-analysis - ScienceDirect
Treating Anemia in CKD in the Era of HIFs: A Ray of Hope? - Renal Fellow Network
A novel family of small molecule HIF-1 alpha stabilizers for the treatment of diabetic wounds; an integrated in silico, in vitro, and in vivo strategy - RSC Advances (RSC Publishing)
HIF-1α is a Potential Molecular Target for Herbal Medicine to Tr | DDDT
The HIF System Response to ESA Therapy in CKD‐Anemia | IntechOpen
The impacts of hypoxia-inducible factor stabilizers on laboratory parameters and clinical outcomes in chronic kidney disease pat
What HIF? Leaving More Questions Than Answers – AJKD Blog
HIF stabilizers in the management of renal anemia: from bench to bedside to pediatrics | Pediatric Nephrology
The oral hypoxia-inducible factor prolyl hydroxylase inhibitor enarodustat counteracts alterations in renal energy metabolism in the early stages of diabetic kidney disease - Kidney International
HIF prolyl-hydroxylase inhibitor - Wikipedia
Stabilization of hypoxia-inducible factor ameliorates glomerular injury sensitization after tubulointerstitial injury - ScienceDirect
IJMS | Free Full-Text | Hypoxia Pathway Proteins are Master Regulators of Erythropoiesis
HIF-1 as a target for drug development | Nature Reviews Drug Discovery
The pro-angiogenic role of hypoxia inducible factor stabilizer FG-4592 and its application in an in vivo tissue engineering chamber model | Scientific Reports
Frontiers | HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
Hypoxia-inducible factor–prolyl hydroxylase inhibitors in the treatment of anemia of chronic kidney disease - Kidney International Supplements
Full article: HIF prolyl hydroxylase inhibitors for anemia
Edgar V. Lerma 🇵🇭 on X: "AGARWAL: HIF stabilizers - safety concerns #Nephpearls #NKFClinicals https://t.co/v82n2tAusp" / X
